nodes	percent_of_prediction	percent_of_DWPC	metapath
Zalcitabine—Subarachnoid haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0361	0.0361	CcSEcCtD
Zalcitabine—Panophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0322	0.0322	CcSEcCtD
Zalcitabine—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.0284	0.0284	CcSEcCtD
Zalcitabine—Haematocrit decreased—Riluzole—amyotrophic lateral sclerosis	0.0211	0.0211	CcSEcCtD
Zalcitabine—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0199	0.0199	CcSEcCtD
Zalcitabine—Dementia—Riluzole—amyotrophic lateral sclerosis	0.0192	0.0192	CcSEcCtD
Zalcitabine—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.0192	0.0192	CcSEcCtD
Zalcitabine—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0168	CcSEcCtD
Zalcitabine—Endophthalmitis—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0165	CcSEcCtD
Zalcitabine—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.0161	0.0161	CcSEcCtD
Zalcitabine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0139	CcSEcCtD
Zalcitabine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.0139	0.0139	CcSEcCtD
Zalcitabine—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.0137	0.0137	CcSEcCtD
Zalcitabine—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0131	CcSEcCtD
Zalcitabine—Respiratory distress—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0124	CcSEcCtD
Zalcitabine—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.012	0.012	CcSEcCtD
Zalcitabine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.0117	0.0117	CcSEcCtD
Zalcitabine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0115	CcSEcCtD
Zalcitabine—Hypercalcaemia—Riluzole—amyotrophic lateral sclerosis	0.0113	0.0113	CcSEcCtD
Zalcitabine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0112	0.0112	CcSEcCtD
Zalcitabine—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.0111	0.0111	CcSEcCtD
Zalcitabine—Mania—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0108	CcSEcCtD
Zalcitabine—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0106	CcSEcCtD
Zalcitabine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Zalcitabine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.0105	0.0105	CcSEcCtD
Zalcitabine—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.0101	0.0101	CcSEcCtD
Zalcitabine—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00979	0.00979	CcSEcCtD
Zalcitabine—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00972	0.00972	CcSEcCtD
Zalcitabine—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00972	0.00972	CcSEcCtD
Zalcitabine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00936	0.00936	CcSEcCtD
Zalcitabine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00878	0.00878	CcSEcCtD
Zalcitabine—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00872	0.00872	CcSEcCtD
Zalcitabine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00866	0.00866	CcSEcCtD
Zalcitabine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00866	0.00866	CcSEcCtD
Zalcitabine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00854	0.00854	CcSEcCtD
Zalcitabine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00849	0.00849	CcSEcCtD
Zalcitabine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00843	0.00843	CcSEcCtD
Zalcitabine—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00832	0.00832	CcSEcCtD
Zalcitabine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00802	0.00802	CcSEcCtD
Zalcitabine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00797	0.00797	CcSEcCtD
Zalcitabine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00787	CcSEcCtD
Zalcitabine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00787	0.00787	CcSEcCtD
Zalcitabine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00769	0.00769	CcSEcCtD
Zalcitabine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.0076	0.0076	CcSEcCtD
Zalcitabine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00752	0.00752	CcSEcCtD
Zalcitabine—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00739	0.00739	CcSEcCtD
Zalcitabine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00723	0.00723	CcSEcCtD
Zalcitabine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0069	0.0069	CcSEcCtD
Zalcitabine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00683	0.00683	CcSEcCtD
Zalcitabine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00676	0.00676	CcSEcCtD
Zalcitabine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.0067	0.0067	CcSEcCtD
Zalcitabine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.0067	0.0067	CcSEcCtD
Zalcitabine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00657	0.00657	CcSEcCtD
Zalcitabine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00657	0.00657	CcSEcCtD
Zalcitabine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00639	0.00639	CcSEcCtD
Zalcitabine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00639	0.00639	CcSEcCtD
Zalcitabine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00616	0.00616	CcSEcCtD
Zalcitabine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00608	0.00608	CcSEcCtD
Zalcitabine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00606	0.00606	CcSEcCtD
Zalcitabine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00603	0.00603	CcSEcCtD
Zalcitabine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00593	0.00593	CcSEcCtD
Zalcitabine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00588	0.00588	CcSEcCtD
Zalcitabine—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00586	CcSEcCtD
Zalcitabine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00574	0.00574	CcSEcCtD
Zalcitabine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00571	0.00571	CcSEcCtD
Zalcitabine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00571	0.00571	CcSEcCtD
Zalcitabine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00567	0.00567	CcSEcCtD
Zalcitabine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00563	0.00563	CcSEcCtD
Zalcitabine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00563	0.00563	CcSEcCtD
Zalcitabine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00558	0.00558	CcSEcCtD
Zalcitabine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00543	0.00543	CcSEcCtD
Zalcitabine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00541	CcSEcCtD
Zalcitabine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00537	0.00537	CcSEcCtD
Zalcitabine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0052	0.0052	CcSEcCtD
Zalcitabine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00506	CcSEcCtD
Zalcitabine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00504	0.00504	CcSEcCtD
Zalcitabine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00497	0.00497	CcSEcCtD
Zalcitabine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00494	CcSEcCtD
Zalcitabine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00484	CcSEcCtD
Zalcitabine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00462	CcSEcCtD
Zalcitabine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00462	CcSEcCtD
Zalcitabine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00456	0.00456	CcSEcCtD
Zalcitabine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00451	0.00451	CcSEcCtD
Zalcitabine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00447	0.00447	CcSEcCtD
Zalcitabine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00439	CcSEcCtD
Zalcitabine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00432	0.00432	CcSEcCtD
Zalcitabine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00429	0.00429	CcSEcCtD
Zalcitabine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00415	0.00415	CcSEcCtD
Zalcitabine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00413	0.00413	CcSEcCtD
Zalcitabine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00396	0.00396	CcSEcCtD
Zalcitabine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00395	0.00395	CcSEcCtD
Zalcitabine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00393	0.00393	CcSEcCtD
Zalcitabine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00392	0.00392	CcSEcCtD
Zalcitabine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00369	0.00369	CcSEcCtD
Zalcitabine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00355	CcSEcCtD
Zalcitabine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00353	0.00353	CcSEcCtD
Zalcitabine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00349	CcSEcCtD
Zalcitabine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00339	CcSEcCtD
Zalcitabine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00338	0.00338	CcSEcCtD
Zalcitabine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00337	0.00337	CcSEcCtD
Zalcitabine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00334	0.00334	CcSEcCtD
Zalcitabine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00333	CcSEcCtD
Zalcitabine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00331	0.00331	CcSEcCtD
Zalcitabine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00322	0.00322	CcSEcCtD
Zalcitabine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00319	0.00319	CcSEcCtD
Zalcitabine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00318	0.00318	CcSEcCtD
Zalcitabine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00316	CcSEcCtD
Zalcitabine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0031	0.0031	CcSEcCtD
Zalcitabine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00309	CcSEcCtD
Zalcitabine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00309	0.00309	CcSEcCtD
Zalcitabine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00308	CcSEcCtD
Zalcitabine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00304	CcSEcCtD
Zalcitabine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00302	CcSEcCtD
Zalcitabine—Cough—Riluzole—amyotrophic lateral sclerosis	0.003	0.003	CcSEcCtD
Zalcitabine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00298	0.00298	CcSEcCtD
Zalcitabine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00297	CcSEcCtD
Zalcitabine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00293	CcSEcCtD
Zalcitabine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00293	CcSEcCtD
Zalcitabine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00292	CcSEcCtD
Zalcitabine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00289	0.00289	CcSEcCtD
Zalcitabine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00287	0.00287	CcSEcCtD
Zalcitabine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00283	0.00283	CcSEcCtD
Zalcitabine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00281	CcSEcCtD
Zalcitabine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00279	CcSEcCtD
Zalcitabine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00276	CcSEcCtD
Zalcitabine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00275	CcSEcCtD
Zalcitabine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00274	0.00274	CcSEcCtD
Zalcitabine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00273	CcSEcCtD
Zalcitabine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00272	0.00272	CcSEcCtD
Zalcitabine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00268	CcSEcCtD
Zalcitabine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00256	CcSEcCtD
Zalcitabine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00254	CcSEcCtD
Zalcitabine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0025	CcSEcCtD
Zalcitabine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0025	CcSEcCtD
Zalcitabine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00247	CcSEcCtD
Zalcitabine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00244	0.00244	CcSEcCtD
Zalcitabine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00242	CcSEcCtD
Zalcitabine—Pain—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0024	CcSEcCtD
Zalcitabine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00231	CcSEcCtD
Zalcitabine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0023	0.0023	CcSEcCtD
Zalcitabine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00223	CcSEcCtD
Zalcitabine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00222	CcSEcCtD
Zalcitabine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00222	0.00222	CcSEcCtD
Zalcitabine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00207	CcSEcCtD
Zalcitabine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00202	0.00202	CcSEcCtD
Zalcitabine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00199	CcSEcCtD
Zalcitabine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00192	0.00192	CcSEcCtD
Zalcitabine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00186	CcSEcCtD
Zalcitabine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00179	CcSEcCtD
Zalcitabine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00177	CcSEcCtD
Zalcitabine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00177	CcSEcCtD
Zalcitabine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00176	CcSEcCtD
